Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
| Conditions: | Esophageal Cancer|Lung Cancer|Malignant Mesothelioma|Metastatic Cancer |
| Start Date: | November 1, 2004 |
| Phase: | Phase I |
| Status: | Recruiting |
| NCT ID: | NCT00098644 |
| Study Type: | Interventional |
| Intervention: | Drug: alvocidib|Drug: romidepsin |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 48 |
| Funded By: | NIH |
| First Received: | December 7, 2004 |
| End Date: | |
| Last Updated: | July 7, 2009 |
| Last Verified: | July 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
